Jennifer Kelly Burzawa MD
Gynecologic Oncology
Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, M. D. Anderson Cancer Center- Katy
Join to View Full Profile
3915 Talbot Rd SSte 300Renton, WA 98055
Phone+1 425-690-3409
Fax+1 425-690-9004
Dr. Burzawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2008 - 2012
Baylor College of MedicineResidency, Obstetrics and Gynecology, 2004 - 2008
University of Miami Leonard M. Miller School of MedicineClass of 2004
Certifications & Licensure
WA State Medical License 2018 - 2026
TX State Medical License 2009 - 2019
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 6 citationsUterine lavage identifies cancer mutations and increasedsomatic mutation burden in individuals with ovarian cancer.Talayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, Enna Manhardt, Marc R Radke
Cancer Research Communications. 2022-10-01 - 57 citationsProspective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.Shannon N. Westin, Bryan Fellman, Charlotte C. Sun, Russell Broaddus, Misty L. Woodall
American Journal of Obstetrics and Gynecology. 2021-02-01 - 6 citationsCorrelation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer.Nicole D. Fleming, Shannon N. Westin, Larissa A. Meyer, Aaron Shafer, Jose Alejandro Rauh-Hain
International Journal of Gynecological Cancer. 2019-09-01
Journal Articles
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerShannon N Westin, Lois M Ramondetta, Kathleen M Schmeler, Pamela T Soliman, Nicole D Fleming, Jennifer K Burzawa, Alpa M Nick, Andrea M Milbourne, Diane C Bodurka, Rob..., American Journal of Obstetrics and Gynecology
Authored Content
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
Professional Memberships
- Society of Gynecologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
